CTNM vs IP · $429.6M cap vs P/E 43, rev $11.97B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported IP revenue for 2026-06-30 was $11.97B. Net income was $48.0M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
CTNM currently screens at market cap $429.6M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CTNM and IP stock pages for the full models.
Not investment advice.